Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis

被引:132
作者
Dargani, Zahra Tavakoli [1 ]
Singla, Dinender K. [1 ]
机构
[1] Univ Cent Florida, Div Metab & Cardiovasc Sci, Burnett Sch Biomed Sci, Coll Med, 4110 Libra Dr, Orlando, FL 32816 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2019年 / 317卷 / 02期
基金
美国国家卫生研究院;
关键词
cardiotoxicity; doxorubicin; exosomes; H9c2; cells; inflammation; pyroptosis; stem cells; NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; GASDERMIN-D; PROINFLAMMATORY CYTOKINES; INDUCED CARDIOMYOPATHY; INDUCED CARDIOTOXICITY; MOLECULAR-MECHANISMS; CARDIAC-FUNCTION; HEART; APOPTOSIS;
D O I
10.1152/ajpheart.00056.2019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Doxorubicin (Dox)-induced cardiac side effects are regulated through increased oxidative stress and apoptosis. However, it remains unknown whether Dox induces the specific inflammatory-mediated form of cell death called pyroptosis. The current study is undertaken to determine whether Dox induces pyroptosis in an in vitro model and to test the potential of exosomes derived from embryonic stem cells (ES-Exos) in inhibiting pyroptosis. H9c2 cells were exposed to Dox to generate pyroptosis and then subsequently treated with exosomes to investigate the protective effects of ES-Exos. Mouse embryonic fibroblast-exosomes (MEF-Exos) were used as a cell line control. We confirmed pyroptosis by analyzing the presence of Toll-like receptor 4 (TLR4)-pyrin domain containing-3 (NLRP3) inflammasome that initiates pyroptosis, which was further confirmed with pyroptotic markers caspase-1, IL-1 beta, caspase-11, and gasdermin-D. The presence of inflammation was confirmed for proinflammatory cytokines, TNF-alpha, and IL-6. Our data show that Dox exposure significantly (P < 0.05) increases expression of TLR4, NLRP3, pyroptotic markers (caspase-1, IL-1 beta, caspase-11, and gasdermin-D), and proinflammatory cytokines (TNF-alpha and IL-6) in H9c2 cells. The increased expression of inflammasome, pyroptosis, and inflammation was significantly (P < 0.05) inhibited by ES-Exos. Interestingly, our cell line control, MEF-Exos, did not show any protective effects. Furthermore, our cytokine array data suggest increased anti-inflammatory (IL-4, IL-9, and IL-13) and decreased proinflammatory cytokines (Fas ligand, IL-12, and TNF-alpha) in ES-Exos, suggesting that anti-inflammatory cytokines might be mediating the protective effects of ES-Exos. In conclusion, our data show that Dox induces pyroptotic cell death in the H9c2 cell culture model and is attenuated via treatment with ES-Exos. NEW & NOTEWORTHY Doxorubicin (Dox)-induced cardiotoxicity is mediated through increased oxidative stress, apoptosis, and necrosis. We report for the first time as per the best of our knowledge that Dox initiates Toll-like receptor 4 and pyrin domain containing-3 inflammasome formation and induces caspase-1-mediated inflammatory pyroptotic cell death in H9c2 cells. Moreover, we establish that inflammation and pyroptosis is inhibited by embryonic stem cell-derived exosomes that could be used as a future therapeutic option to treat Dox-induced cardiotoxicity.
引用
收藏
页码:H460 / H471
页数:12
相关论文
共 103 条
[71]   Stem cells and exosomes in cardiac repair [J].
Singla, Dinender K. .
CURRENT OPINION IN PHARMACOLOGY, 2016, 27 :19-23
[72]   Akt-mTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity Following Embryonic Stem Cell Transplantation [J].
Singla, Dinender K. .
CELL TRANSPLANTATION, 2015, 24 (06) :1031-1042
[73]   Embryonic Stem Cells and Released Factors Stimulate c-kit+/FLK-1+ Progenitor Cells and Promote Neovascularization in Doxorubicin-Induced Cardiomyopathy [J].
Singla, Dinender K. ;
Abdelli, Latifa S. .
CELL TRANSPLANTATION, 2015, 24 (06) :1043-1052
[74]   Embryonic Stem Cells Improve Cardiac Function in Doxorubicin-Induced Cardiomyopathy Mediated Through Multiple Mechanisms [J].
Singla, Dinender K. ;
Ahmed, Aisha ;
Singla, Reetu ;
Yan, Binbin .
CELL TRANSPLANTATION, 2012, 21 (09) :1919-1930
[75]   Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle [J].
Smuder, Ashley J. ;
Kavazis, Andreas N. ;
Min, Kisuk ;
Powers, Scott K. .
JOURNAL OF APPLIED PHYSIOLOGY, 2011, 111 (04) :1190-1198
[76]   Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases [J].
Song, Yao-Hua ;
Shao, Lianbo ;
Zhang, Yu ;
Zhou, Jin ;
Liu, Bin ;
Pan, Xiangbin ;
Geng, Yong-jian ;
Yu, Xi-yong ;
Li, Yangxin .
EXOSOMES IN CARDIOVASCULAR DISEASES: BIOMARKERS, PATHOLOGICAL AND THERAPEUTIC EFFECTS, 2017, 998 :187-206
[77]   Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro [J].
Sun, Jing ;
Sun, Guibo ;
Meng, Xiangbao ;
Wang, Hongwei ;
Luo, Yun ;
Qin, Meng ;
Ma, Bo ;
Wang, Min ;
Cai, Dayong ;
Guo, Peng ;
Sun, Xiaobo .
PLOS ONE, 2013, 8 (05)
[78]   Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium [J].
Swijnenburg, RJ ;
Tanaka, M ;
Vogel, H ;
Baker, J ;
Kofidis, T ;
Gunawan, F ;
Lebl, DR ;
Caffarelli, AD ;
de Bruin, JL ;
Fedoseyeva, EV ;
Robbins, RC .
CIRCULATION, 2005, 112 (09) :I166-I172
[79]   Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems [J].
Tacar, Oktay ;
Sriamornsak, Pornsak ;
Dass, Crispin R. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (02) :157-170
[80]   Ablation of Bax and Bak protects skeletal muscle against pressure-induced injury [J].
Tam, Bjorn T. ;
Yu, Angus P. ;
Tam, Eric W. ;
Monks, Douglas A. ;
Wang, Xu P. ;
Pei, Xiao M. ;
Koh, Su P. ;
Sin, Thomas K. ;
Law, Helen K. W. ;
Ugwu, Felix N. ;
Supriya, Rashmi ;
Yung, Benjamin Y. ;
Yip, Shea P. ;
Wong, S. C. ;
Chan, Lawrence W. ;
Lai, Christopher W. ;
Ouyang, Pin ;
Siu, Parco M. .
SCIENTIFIC REPORTS, 2018, 8